2 These potential problems can be easily overcome by using transdermal delivery of Lovastatin but previously

reported problem of crystallization of many statins in polymers used in transdermal drug delivery system is the matter of concern in controlled and precise delivery of statin drugs through such dosage forms.3 Iontophoresis is generally possible for transdermal delivery of ionized drug molecules. Many investigators have reported possibility of Iontophoresis of non-ionic lipophilic drugs by artificially generation of charge on drug molecule by use of surfactants or charge Selleck Pomalidomide coupling by complexation.4 Micellar solubilization of drug by ionic surfactant can fulfil two aspects, one is charge generation and the other is drug solubilization. Dodecyltrimethylammonium bromide

(DTAB) is a cationic surfactant. It is preferred for transdermal delivery because an anionic surfactant may damage skin more adversely than a cationic surfactant.5 Moreover, small molecular weight of DTAB (∼285 Da) in comparison of other quaternary ammonium cationic surfactants make it a preferred surfactant for micelle formation for delivery of Lovastatin. The present work was aimed to investigate effect of LY2835219 mw DTAB micelles on Lovastatin permeation through skin during Iontophoresis. Study of potential formulation factors and operational factor was also intended during Iontophoresis of selected lipophilic drug. Lovastatin was obtained as gift sample from hetero drugs (Hyderabad, India). DTAB was purchased from sigma Aldrich (Mumbai, India). Sodium chloride, Sodium hydroxide, Polyethylene glycol (PEG 400) and potassium dihydrogen phosphate were purchased from Astron Chemicals (Ahmedabad, India). Organic solvents used were of HPLC grade and obtained from Merck India (Mumbai, India). Solubility of Lovastatin was determined

in solution containing critical micelle concentration of DTAB to fix the drug loading extent. Effect of various temperature conditions, room temperature (25 °C), operational temperature (37 °C) and accelerated stability study condition (40 °C) were studied TCL on CMC of DTAB. Solution of Lovastatin in double distilled, deionized water containing 10% v/v PEG 400 was used as control standard. This solution was used for passive in-vitro permeation study by mounting isolated rat skin as partitioning membrane. Modified Glickfeld diffusion cells were used for 12 h in-vitro Iontophoresis study presented in this research work.6 Enhancement ratio of in-vitro permeation of Lovastatin was studied by using three vehicle compositions as mentioned in Table 1. Iontophoresis of three compositions LVI 1, LVI 2 and LVI 3 was carried out by using DC power source (Mfg by Chromtech ltd, Thane, India). Silver/silver chloride electrodes were used in this Anodal iontophoretic experiments. 0.25 mA/cm2 density continuous current supply was kept as constant process parameters.